hɪz ɹᵻsˈɜːtʃ ˈɪntɹɛsts ɪŋklˈuːd vˈaɪɾəmɪn ænd ɐmˈiːnoʊ ˈæsɪd bˌaɪoʊsˈɪnθəsˌɪs æz tˈɑːɹɡɪts fɚðə ɹˈæʃənəl dɪzˈaɪn ʌv ˌæntɪmaɪkɹˈoʊbɪəlz; fɹˈæɡməntbˈeɪst ɐpɹˈoʊtʃᵻz tʊ ˈɛnzaɪm ɪnhɪbˈɪʃən; bæktˈɪɹiəl ænd plˈænt ɹˈɪbəswˌɪtʃᵻz; ɹɪˈækʃənz ɪn mˈaɪkɹoʊdɹˌɑːplɪts; ænd bˌaɪəlˈɑːdʒɪkəl nˌænoʊtɛknˈɑːlədʒi.
His research interests include vitamin and amino acid biosynthesis as targets for the rational design of antimicrobials; fragment-based approaches to enzyme inhibition; bacterial and plant riboswitches; reactions in microdroplets; and biological nanotechnology.